Experimental GPC3‑Targeted CAR T Therapy Clears Metastatic Liver Cancer in 3‑Year‑Old After Two Doses

A three‑year‑old boy with metastatic hepatoblastoma experienced complete regression after two outpatient infusions of an experimental GPC3‑targeted CAR T therapy engineered to express IL‑15 and IL‑21. The patie...



























